The Clinical Proteomic Technologies for Cancer Antibody Portal
OVERVIEW
ANTIBODIES.CANCER.GOV TRAFFIC
Date Range
Date Range
Date Range
LINKS TO ANTIBODIES.CANCER.GOV
The National Institutes of Health. Clinical Proteomics Technologies for Cancer. Sign Up for Email Updates. Pharmacodynamic Proteomic Assay Panel for Monitoring Phospho-Signaling Networks. CPTAC researchers demonstrate utility of a pharmacodynamic multiplex immuno-MRM assay to study phosphorylated cell signaling networks. For more information, click here. CPTAC Proteomics Data Now on UCSC Genome Browser. For more information click here. Investigating RAS Signaling in Cancer.
WHAT DOES ANTIBODIES.CANCER.GOV LOOK LIKE?
ANTIBODIES.CANCER.GOV SERVER
FAVICON
SERVER SOFTWARE AND ENCODING
We found that this domain is implementing the Apache operating system.SITE TITLE
The Clinical Proteomic Technologies for Cancer Antibody PortalDESCRIPTION
An objective of the Reagents and Resources component of NCIs Clinical Proteomic Technologies for Cancer Initiative is to generate highly characterized monoclonal antibodies to human proteins associated with cancer.PARSED CONTENT
The web site antibodies.cancer.gov had the following in the web site, "The National Institutes of Health." I noticed that the webpage stated " Clinical Proteomics Technologies for Cancer." They also said " Sign Up for Email Updates. US Department of Health and Human Services." The meta header had Antigen as the first optimized keyword. This keyword is followed by Antibody, Antigens, and Antibodies which isn't as important as Antigen. The other words antibodies.cancer.gov used was Research. NCI is included but could not be seen by search crawlers.SEE SIMILAR WEB SITES
Welcome to Antibodies Australia! Our mission is to develop an Australian-owned source of high quality antibodies and. Serum products for the Australian and International biotechnological research and industrial. Market at a reasonable price.
Custom Antibody Services and Immunoassays. Better Antigens, Better Antibodies, Better Assays. Genomic Antibody Technology White Paper. SDIX Sells Life Science Assets to OriGene Technologies, Inc. Novus Biologicals Announces New ROBLD3 Antibody made using SDIX Genomic Antibody Technology.
Is a manufacturer and distributor. And diagnostic kits and a developer. We manufacture using cGLP and cGMP as audited by BSI and certified as ISO 13485-2003. Antibodies Incorporated has been a supplier of secondary, custom polyclonal and monoclonal. Antibodies and immunochemistry products and services for more than forty-two years.
Invite someone to join? We are a NPO and we need your help. Keeping track of antibodies has never been so easy. Stay up to date with your team. By joining Antibody-Adviser, you also gain the ability to create and manage teams. That way you will never miss informations about antibodies. That have been used in your lab! No one except team members are able to access the team pages. All your antibodies in one place. One click, one PDF, from web to bench! Do more with your dig.